FDA.reportPublic FDA data

Dificid 40 MG/mL Oral Suspension

RxCUI
2279847
RxNorm name
Dificid 40 MG/mL Oral Suspension
Display name
Dificid 40 MG/mL Oral Suspension
Full name
Dificid 40 MG/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DificidFIDAXOMICINMerck Sharp & Dohme LLCdd966338-c820-4270-b704-09ef75fa3ceb2024-10-16Warnings, Adverse reactionsExact identifier
rxcui: 2279847

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dd966338-c820-4270-b704-09ef75fa3cebDificid 40 MG/mL Oral Suspension [PSN] · fidaxomicin 40 MG/ML Oral Suspension [Dificid] [SBD] · Dificid 40 MG/ML Oral Suspension [SY]321These highlights do not include all the information needed to use DIFICID safely and effectively. See full prescribing information for DIFICID. DIFICID ® (fidaxomicin) tablets, for oral use DIFICID ® (fidaxomicin) for oral suspension Initial U.S. Approval: 201120241016